[18F]-flutemetamol amyloid imaging along the continuum from normal cognitive status to Alzheimer's disease dementia.
Phase of Trial: Phase II
Latest Information Update: 14 Aug 2018
At a glance
- Drugs Flutemetamol-F-18 (Primary)
- Indications Alzheimer's disease; Cognition disorders
- Focus Diagnostic use
- 14 Aug 2018 New trial record